Kratom can affect blood pressure, though the direction and severity depend heavily on the dose, the individual, and whether use is acute or chronic. At lower amounts, kratom tends to act as a stimulant, which can raise blood pressure and heart rate. At higher amounts, its opioid-like sedative properties dominate, which may lower blood pressure. Both patterns carry cardiovascular risks, and neither is predictable enough to be considered safe.
How Kratom Interacts With Your Cardiovascular System
Kratom leaves contain more than 50 active alkaloids, but two do most of the heavy lifting: mitragynine and 7-hydroxymitragynine. Both bind to the same opioid receptors in the brain that drugs like codeine target. But mitragynine doesn’t stop there. It also interacts with the brain’s norepinephrine, serotonin, and dopamine systems, according to the FDA. This mix of pathways is what makes kratom’s cardiovascular effects complex and somewhat unpredictable.
Norepinephrine is the key player for blood pressure. It’s the chemical your body uses to tighten blood vessels and speed up the heart during stress or physical activity. When kratom activates norepinephrine pathways, it can push blood pressure upward the same way a strong cup of coffee or a stressful event would. At the same time, its opioid activity can slow heart rate and relax blood vessels, pulling pressure in the opposite direction. Which effect wins depends largely on dose.
Low Doses vs. High Doses
Kratom’s dose-dependent behavior is one of its most distinctive and confusing traits. At lower doses (roughly 1 to 5 grams of dried leaf), users commonly report stimulant-like effects: increased energy, alertness, and elevated heart rate. This stimulant profile is consistent with a temporary rise in blood pressure, driven by the norepinephrine and dopamine activity of mitragynine.
At higher doses (roughly 5 to 15 grams), the opioid effects take over. Users feel sedated, relaxed, and sometimes euphoric. Heart rate and blood pressure may drop, similar to what happens with traditional opioids. In some cases, this drop can be significant enough to cause lightheadedness or fainting, particularly in people who are already on blood pressure medication or are dehydrated.
The problem is that these ranges are rough guidelines, not precise thresholds. Kratom products are unregulated, so the actual alkaloid concentration varies widely between batches, brands, and strains. A “low dose” from one product might deliver the same alkaloid load as a “high dose” from another. This inconsistency makes it genuinely difficult to predict how any given serving will affect your cardiovascular system.
Reported Cardiovascular Events
Case reports in the medical literature have documented a range of cardiovascular problems in kratom users, including rapid heart rate (tachycardia), high blood pressure episodes, and in rare cases, more serious events like abnormal heart rhythms. These reports typically involve people who used high doses, combined kratom with other substances, or had preexisting heart conditions. While serious cardiovascular emergencies from kratom alone appear uncommon, the lack of large-scale clinical studies means the true risk is still poorly understood.
The FDA has warned consumers not to use kratom, citing risks including liver toxicity, seizures, and substance use disorder. The agency has not issued a specific warning about blood pressure, but the pharmacological profile of kratom’s alkaloids, particularly their ability to stimulate multiple neurotransmitter systems simultaneously, creates a plausible mechanism for cardiovascular stress.
Blood Pressure Changes During Withdrawal
If you’ve been using kratom regularly and stop, blood pressure fluctuations are a recognized part of the withdrawal experience. The body adapts to kratom’s influence on norepinephrine and opioid receptors over time. When the substance is removed, those systems can rebound. For many people, this means temporary spikes in blood pressure and heart rate, along with other withdrawal symptoms like anxiety, irritability, muscle aches, and insomnia. These rebound effects are similar to what happens during opioid withdrawal and typically peak within the first few days of stopping, then gradually improve over one to two weeks.
Risks for People With Existing Blood Pressure Issues
If you already have high blood pressure, take blood pressure medication, or have any cardiovascular condition, kratom introduces unpredictable variables. The stimulant effects at lower doses could counteract your medication. The sedative effects at higher doses could cause a dangerous drop on top of what your medication is already doing. Either scenario is a problem, and because kratom products lack standardized dosing, there’s no reliable way to control for it.
Combining kratom with other substances that affect blood pressure compounds the risk further. This includes caffeine, alcohol, stimulants, and prescription medications for heart conditions, depression, or anxiety. Many of the serious adverse events reported in medical literature involve polydrug use rather than kratom in isolation.
Why Research Is Still Limited
One reason it’s hard to give precise blood pressure numbers for kratom use is that controlled clinical trials in humans are extremely scarce. Most of what we know comes from animal studies, case reports of people who showed up in emergency rooms, and surveys of self-reported users. None of these sources provide the kind of rigorous, controlled data that would let researchers say “X grams of kratom raises systolic pressure by Y points in the average person.” The variability in kratom products makes this even harder to study, since researchers can’t easily standardize the dose across participants.
What the existing evidence does consistently show is that kratom is pharmacologically active on multiple systems that regulate blood pressure. It is not a neutral substance from a cardiovascular standpoint, even if the exact magnitude of its effects remains difficult to quantify in a general way. For anyone monitoring their blood pressure closely, whether due to hypertension, heart disease, or medication interactions, that uncertainty itself is a meaningful risk factor.